Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Yasumasa, Higuchi, Makoto, Zhang, Bin, Huang, Shu-Ming, Iwata, Nobuhisa, Saido, Takaomi C., Maeda, Jun, Suhara, Tetsuya +2 more·2007·Neuron

Cited by (1,029)

Items 201–300 of 1,029

  1. Intersection of pathological tau and microglia at the synapse
    Vogels, Thomas, Murgoci, Adriana-Natalia, Hromádka, Tomáš · 2019 · Acta Neuropathologica Communications
  2. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice
    Peeraer, Eve, Bottelbergs, Astrid, Van Kolen, Kristof, Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Mahieu, Michel, Duytschaever, Hilde, Ver Donck, Luc, Torremans, An, Sluydts, Ellen et al. · 2015 · Neurobiology of Disease
  3. Mouse Models of Alzheimer’s Disease
    Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
  4. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss
    Rahasson R. Ager, Joy L. Davis, Andy Agazaryan, Francisca Benavente, Wayne W. Poon, Frank M. LaFerla, Mathew M. Blurton-Jones · 2014 · Hippocampus
  5. Axonal degeneration in Alzheimer's disease: When signaling abnormalities meet the axonal transport system
    Nicholas M. Kanaan, Gustavo F. Pigino, Scott T. Brady, Orly Lazarov, Lester I. Binder, Gerardo A. Morfini · 2012 · Experimental Neurology
  6. Inflammation in the early stages of neurodegenerative pathology
    Preeti J. Khandelwal, Alexander M. Herman, Charbel Moussa · 2011 · Journal of Neuroimmunology
  7. Transcriptional and epigenetic decoding of the microglial aging process
    Xiaoyu Li, Yuxin Li, Yuxiao Jin, Yuheng Zhang, Jingchuan Wu, Zhen Xu, Yubin Huang, Lin Cai, Shuai Gao, Taohui Liu et al. · 2023 · Nature Aging
  8. Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic Mice
    Sy, Michael, Kitazawa, Masashi, Medeiros, Rodrigo, Whitman, Lucia, Cheng, David, Lane, Thomas E., LaFerla, Frank M. · 2011 · The American Journal of Pathology
  9. Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
    Natalia Louneva, Julia Wanda Cohen, Liying Han, Konrad Talbot, Robert S. Wilson, David Alan Bennett, John Q. Trojanowski, Steven Edward Arnold · 2008 · American Journal Of Pathology
  10. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
    Meilandt, William J., Ngu, Hai, Gogineni, Alvin, Lalehzadeh, Guita, Lee, Seung-Hye, Srinivasan, Karpagam, Imperio, Jose, Wu, Tiffany, Weber, Martin, Kruse, Agatha J. et al. · 2020 · The Journal of Neuroscience
  11. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies
    Mark M. Yarchoan, Jon B. Toledo, Edward B. Lee, Zoe Arvanitakis, Hala Kazi, Li-Ying Han, Natalia Louneva, Virginia M.‐Y. Lee, Sangwon F. Kim, John Q. Trojanowski et al. · 2014 · Acta Neuropathologica
  12. Updates in Alzheimer's disease: from basic research to diagnosis and therapies
    Enjie Liu, Yao Zhang, Jian–Zhi Wang · 2024 · Translational Neurodegeneration
  13. CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
    Meena S. Subbarayan, Aurélie Joly‐Amado, Paula C. Bickford, Kevin R. Nash · 2021 · Pharmacology & Therapeutics
  14. APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints
    Yin, Zhuoran, Rosenzweig, Neta, Kleemann, Kilian L., Zhang, Xiaoming, Brandão, Wesley, Margeta, Milica A., Schroeder, Caitlin, Sivanathan, Kisha N., Silveira, Sebastian, Gauthier, Christian et al. · 2023 · Nature Immunology
  15. Traumatic Brain Injury Induces Tau Aggregation and Spreading
    Edwards, George, Zhao, Jing, Dash, Pramod K., Soto, Claudio, Moreno-Gonzalez, Ines · 2020 · Journal of Neurotrauma
  16. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis
    Russell L. Blaylock, Joseph C. Maroon · 2011 · Surgical Neurology International
  17. Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
    Malpetti, Maura, Kievit, Rogier A, Passamonti, Luca, Jones, P Simon, Tsvetanov, Kamen A, Rittman, Timothy, Mak, Elijah, Nicastro, Nicolas, Bevan-Jones, W Richard, Su, Li et al. · 2020 · Brain
  18. Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies
    Bien-Ly, Nga, Boswell, C. Andrew, Jeet, Surinder, Beach, Thomas G., Hoyte, Kwame, Luk, Wilman, Shihadeh, Vera, Ulufatu, Sheila, Foreman, Oded, Lu, Yanmei et al. · 2015 · Neuron
  19. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
    Wenkai Li, Jeffrey B. Sperry, Alex Crowe, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee · 2009 · Journal of Neurochemistry
  20. Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies
    Carlo Ballatore, Kurt R. Brunden, Donna M. Huryn, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith · 2012 · Journal of Medicinal Chemistry
  21. Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease
    Liang Zhang, Sergey Trushin, Trace A. Christensen, Benjamin V. Bachmeier, Benjamin Gateno, Andreas Schroeder, Jia Yao, Kie Itoh, Hiromi Sesaki, Wayne W. Poon et al. · 2016 · Scientific Reports
  22. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
    Cyril Laurent, S. Eddarkaoui, Maxime J Derisbourg, A. Leboucher, D. Demeyer, Sébastien Carrier, Marion Schneider, M. Hamdane, C. Müller, L. Buée et al. · 2014 · Neurobiology of Aging
  23. Tau local structure shields an amyloid-forming motif and controls aggregation propensity
    Dailu Chen, Kenneth W. Drombosky, Zhiqiang Hou, Levent Sari, Omar M. Kashmer, Bryan D. Ryder, Valerie A. Perez, DaNae R. Woodard, Milo M. Lin, Marc I. Diamond et al. · 2019 · Nature Communications
  24. Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
    S. Meftah, Jian Gan · 2023 · Frontiers in Synaptic Neuroscience
  25. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
    Erik Nutma, Nurun Nahar Fancy, Maria Weinert, Stergios Tsartsalis, Manuel C. Marzin, Robert C. J. Muirhead, Irene N. Falk, Marjolein Breur, Joy de Bruin, David Hollaus et al. · 2023 · Nature Communications
  26. Caspase-2 cleavage of tau reversibly impairs memory
    Zhao, Xiaohui, Kotilinek, Linda A, Smith, Benjamin, Hlynialuk, Chris, Zahs, Kathleen, Ramsden, Martin, Cleary, James, Ashe, Karen H · 2016 · Nature Medicine
  27. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
    Vasconcelos, Bruno, Stancu, Ilie-Cosmin, Buist, Arjan, Bird, Matthew, Wang, Peng, Vanoosthuyse, Alexandre, Van Kolen, Kristof, Verheyen, An, Kienlen-Campard, Pascal, Octave, Jean-Noël et al. · 2016 · Acta Neuropathologica
  28. Chronic Traumatic Encephalopathy: The Neuropathological Legacy of Traumatic Brain Injury
    Jennifer R. Hay, Victoria E. Johnson, Douglas H. Smith, William B. Stewart Jr. · 2016 · Annual Review of Pathology Mechanisms of Disease
  29. TREM2 dependent and independent functions of microglia in Alzheimer’s disease
    Hou, Jinchao, Chen, Yun, Grajales-Reyes, Gary, Colonna, Marco · 2022 · Molecular Neurodegeneration
  30. Reactive astrocytes in Alzheimer’s disease: A double-edged sword
    Chun, Heejung, Lee, C. Justin · 2018 · Neuroscience Research
  31. Updates on mouse models of Alzheimer’s disease
    Zhong, Michael Z., Peng, Thomas, Duarte, Mariana Lemos, Wang, Minghui, Cai, Dongming · 2024 · Molecular Neurodegeneration
  32. Anti‐tau antibody reduces insoluble tau and decreases brain atrophy
    Yanamandra, Kiran, Jiang, Hong, Mahan, Thomas E., Maloney, Susan E., Wozniak, David F., Diamond, Marc I., Holtzman, David M. · 2015 · Annals of Clinical and Translational Neurology
  33. Plasma microRNA biomarkers for detection of mild cognitive impairment
    Sheinerman, Kira S., Tsivinsky, Vladimir G., Crawford, Fiona, Mullan, Michael J., Abdullah, Laila, Umansky, Samuil R. · 2012 · Aging
  34. Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system
    Schafer, Dorothy P., Stevens, Beth · 2013 · Current Opinion in Neurobiology
  35. Pathological Tau Disrupts Ongoing Network Activity
    Menkes-Caspi, Noa, Yamin, Hagar G., Kellner, Vered, Spires-Jones, Tara L., Cohen, Dana, Stern, Edward A. · 2015 · Neuron
  36. Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
    Diana Laura Castillo‐Carranza, Julia E. Gerson, Urmi Sengupta, Marcos Jair Guerrero‐Munoz, Cristian A. Lasagna‐Reeves, Rakez Kayed · 2014 · Journal of Alzheimer s Disease
  37. Metal ions as modulators of protein conformation and misfolding in neurodegeneration
    Sónia S. Leal, Hugo M. Botelho, Cláudio M. Gomes · 2012 · Coordination Chemistry Reviews
  38. Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support
    Samuel E. Marsh, Mathew M. Blurton-Jones · 2017 · Neurochemistry International
  39. Fluid Biomarkers for Synaptic Dysfunction and Loss
    Camporesi, Elena, Nilsson, Johanna, Brinkmalm, Ann, Becker, Bruno, Ashton, Nicholas J, Blennow, Kaj, Zetterberg, Henrik · 2020 · Biomarker Insights
  40. Automated quantification of neuronal networks and single-cell calcium dynamics using calcium imaging
    Tapan P. Patel, Karen Man, Bonnie L. Firestein, David F. Meaney · 2015 · Journal of Neuroscience Methods
  41. Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.
    Kitazawa, Masashi, Medeiros, Rodrigo, M. LaFerla, Frank · 2012 · Current Pharmaceutical Design
  42. RETRACTED: Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy
    George J. Francis, Jose A. Martinez, Wei Q Liu, Kevin Xu, Amit B. Ayer, Jared M. Fine, Ursula I. Tuor, Gordon W. Glazner, Leah R. Hanson, William H. Frey et al. · 2008 · Brain · Retracted
  43. Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
    Antonio Cuadrado, Sebastian Kügler, Isabel Lastres‐Becker · 2017 · Redox Biology
  44. BIN1 favors the spreading of Tau via extracellular vesicles
    Crotti, Andrea, Sait, Hameetha Rajamohamend, McAvoy, Kathleen M., Estrada, Karol, Ergun, Ayla, Szak, Suzanne, Marsh, Galina, Jandreski, Luke, Peterson, Michael, Reynolds, Taylor L. et al. · 2019 · Scientific Reports
  45. Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
    Alena Michalicová, Petra Majerová, Andrej Kováč · 2020 · Frontiers in Molecular Neuroscience
  46. Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells
    Amanda L. Woerman, Atsushi Aoyagi, Smita S. Patel, Sabeen A. Kazmi, Iryna V. Lobach, Lea T. Grinberg, Ann Carolyn McKee, William W. Seeley, Steven H. Olson, Stanley B. Prusiner · 2016 · Proceedings of the National Academy of Sciences
  47. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
    Zheng, Yan, Liu, Aiyi, Wang, Zi-Jun, Cao, Qing, Wang, Wei, Lin, Lin, Ma, Kaijie, Zhang, Freddy, Wei, Jing, Matas, Emmanuel et al. · 2019 · Brain
  48. ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
    Kathleen R. Zahs, Karen H. Ashe · 2010 · Trends in Neurosciences
  49. Alzheimer disease pathology as a host response
    Castellani, Rudy J., Lee, Hyoung-gon, Zhu, Xiongwei, Perry, George, Smith, Mark A. · 2008 · Journal of Neuropathology & Experimental Neurology
  50. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling
    Yaling Yin, Di Gao, Yali Wang, Zhi-Hao Wang, Xin Wang, Jinwang Ye, Dongqin Wu, Lin Fang, Guilin Pi, Ying Yang et al. · 2016 · Proceedings of the National Academy of Sciences
  51. Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study
    Alie Schuitemaker, Marc A Kropholler, Ronald Boellaard, Wiesje M. van der Flier, Reina W. Kloet, Thalia F. van der Doef, Dirk L. Knol, Albert D. Windhorst, Gert Luurtsema, Frederik Barkhof et al. · 2012 · Neurobiology of Aging
  52. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
    Albert Christian Ludolph, Jan Kassubek, G. Bernhard Landwehrmeyer, E. Mandelkow, Eva‐Maria Mandelkow, David John Burn, Dominique Caparros-Lefebvre, Kirk A. Frey, Justo Garcı́a de Yébenes, Thomas Gasser et al. · 2009 · European Journal of Neurology
  53. Interactions between APP secretases and inflammatory mediators
    Magdalena Sastre, Jochen Walter, Steve Gentleman · 2008 · Journal of Neuroinflammation
  54. MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
    Rachid El Fatimy, Shaomin Li, Zhicheng Chen, Tasnim Mushannen, Sree Gongala, Zhiyun Wei, Darrick T. Balu, Rosalia Rabinovsky, Adam Cantlon, Abdallah Elkhal et al. · 2018 · Acta Neuropathologica
  55. Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies
    Ji, Bin, Maeda, Jun, Sawada, Makoto, Ono, Maiko, Okauchi, Takashi, Inaji, Motoki, Zhang, Ming-Rong, Suzuki, Kazutoshi, Ando, Kiyoshi, Staufenbiel, Matthias et al. · 2008 · The Journal of Neuroscience
  56. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
    Erik Portelius, Bob Olsson, Kina Höglund, Nicholas C. Cullen, Hlin Kvartsberg, Ulf Andréasson, Henrik Zetterberg, Åsa Sandelius, Leslie M. J. Shaw, Virginia M.‐Y. Lee et al. · 2018 · Acta Neuropathologica
  57. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration
    Zhong, Li, Sheng, Xuan, Wang, Wanbing, Li, Yanzhong, Zhuo, Rengong, Wang, Kai, Zhang, Lianshuai, Hu, Dan-Dan, Hong, Yujuan, Chen, Linting et al. · 2023 · Immunity
  58. Tau Mutations in Neurodegenerative Diseases
    Michael S. Wolfe · 2008 · Journal of Biological Chemistry
  59. Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
    Guerrero-Muñoz, Marcos J., Gerson, Julia, Castillo-Carranza, Diana L. · 2015 · Frontiers in Cellular Neuroscience
  60. Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
    Ashley N. Nilson, Kelsey C. English, Julia E. Gerson, T. Barton Whittle, C. Nicolas Crain, Judy J Xue, Urmi Sengupta, Diana Laura Castillo‐Carranza, Wenbo Zhang, Praveena K. Gupta et al. · 2016 · Journal of Alzheimer s Disease
  61. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease
    Victor Z. Lau, Leanne M. Ramer, Marie‐Ève Tremblay · 2023 · Nature Communications
  62. The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy
    Eckermann, Katrin, Mocanu, Maria-Magdalena, Khlistunova, Inna, Biernat, Jacek, Nissen, Astrid, Hofmann, Anne, Schönig, Kai, Bujard, Hermann, Haemisch, Andreas, Mandelkow, Eckhard et al. · 2007 · Journal of Biological Chemistry
  63. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
    Ruan, Zhi, Delpech, Jean-Christophe, Venkatesan Kalavai, Srinidhi, Van Enoo, Alicia A., Hu, Jianqiao, Ikezu, Seiko, Ikezu, Tsuneya · 2020 · Molecular Neurodegeneration
  64. The Complex Interactions Between Obesity, Metabolism and the Brain
    Romina María Uranga, Jeffrey N. Keller · 2019 · Frontiers in Neuroscience
  65. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
    Jinsoo Seo, Oleg Kritskiy, Lauren Ashley Watson, Scarlett J. Barker, Dilip Chandra Dey, Waseem Khan Raja, Yuan-Ta Lin, Tak Ko, Sukhee Cho, Jay Penney et al. · 2017 · Journal of Neuroscience
  66. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK
    Li, Yajuan, Munoz-Mayorga, Daniel, Nie, Yuhang, Kang, Ningxin, Tao, Yuren, Lagerwall, Jessica, Pernaci, Carla, Curtin, Genevieve, Coufal, Nicole G., Mertens, Jerome et al. · 2024 · Cell Metabolism
  67. The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
    Johanna L. Crimins, Amy M. Pooler, Manuela Polydoro, Jennifer Irene Luebke, Tara L. Spires‐Jones · 2013 · Ageing Research Reviews
  68. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
    Kurt R. Brunden, Yuemang Yao, Justin S. Potuzak, Nuria Ibarz Ferrer, Carlo Ballatore, Michael J. James, Anne‐Marie L. Hogan, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee · 2010 · Pharmacological Research
  69. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology
    Karim Bélarbi, Sylvie Burnouf, Francisco-José Fernández-Gómez, Cyril Laurent, Sophie Lestavel, Martin Figeac, Audrey Sultan, Laëtitia Troquier, Antoine Leboucher, Raphaëlle Caillierez et al. · 2011 · Neurobiology of Disease
  70. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology
    Filip Kosel, Jessica M.S. Pelley, Tamara B. Franklin · 2020 · Neuroscience & Biobehavioral Reviews
  71. Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia
    Ada Ndoja, Rohit Reja, Seung-Hye Lee, Joshua D. Webster, Hai Ngu, Christopher M. Rose, Donald S. Kirkpatrick, Zora D. Modrusan, Ying-Jiun Jasmine Chen, Debra L. Dugger et al. · 2020 · Cell
  72. Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
    Cliona Stack, Shari Jainuddin, Ceyhan Elipenahli, Meri Gerges, Natalia N. Starkova, Anatoly A. Starkov, Mariona Jové, Manuel Portero‐Otín, Nathalie Launay, Aurora Pujol et al. · 2014 · Human Molecular Genetics
  73. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
    Litvinchuk, Alexandra, Suh, Jung H., Guo, Jing L., Lin, Karin, Davis, Sonnet S., Bien-Ly, Nga, Tycksen, Eric, Tabor, G. Travis, Remolina Serrano, Javier, Manis, Melissa et al. · 2024 · Neuron
  74. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer’s disease in the oldest-old
    Robinson, John L., Molina-Porcel, Laura, Corrada, Maria M., Raible, Kevin, Lee, Edward B., Lee, Virginia M.-Y., Kawas, Claudia H., Trojanowski, John Q. · 2014 · Brain
  75. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
    Swarup, Vivek, Hinz, Flora I., Rexach, Jessica E., Noguchi, Ken-ichi, Toyoshiba, Hiroyoshi, Oda, Akira, Hirai, Keisuke, Sarkar, Arjun, Seyfried, Nicholas T., Cheng, Chialin et al. · 2019 · Nature Medicine
  76. Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
    Mariajose Metcalfe, Maria E. Figueiredo‐Pereira · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  77. Role of the peripheral innate immune system in the development of Alzheimer's disease
    Aurélie Y. Le Page, Gilles Dupuis, Eric H. Frost, Anis Larbi, Graham Pawelec, Jacek Maciej Witkowski, Tamàs Fülöp · 2017 · Experimental Gerontology
  78. Accumulation of tau induced in neurites by microglial proinflammatory mediators
    Gorlovoy, Philipp, Larionov, Sergey, Pham, Thao Thi Hien, Neumann, Harald · 2009 · The FASEB Journal
  79. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
    Rosa Maria Tolón, Estefanía Núñez, María Ruth Pazos, Cristina Benito, Ana I. Castillo, José Antonio Martínez-Orgado, Julián Romero · 2009 · Brain Research
  80. Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
    Cristian A. Lasagna‐Reeves, María de Haro, Shuang Hao, Jeehye Park, Maxime W.C. Rousseaux, Ismael Al‐Ramahi, Paymaan Jafar‐Nejad, Luis Vilanova-Velez, Lauren See, Antonia De Maio et al. · 2016 · Neuron
  81. Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behavior
    Gaurav Ghag, Nemil N. Bhatt, Daniel V Cantu, Marcos Jair Guerrero‐Munoz, Anna Ellsworth, Urmi Sengupta, Rakez Kayed · 2018 · Protein Science
  82. Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases
    María Teresa Flores-Dorantes, Yael E. Díaz‐López, Ruth Gutiérrez‐Aguilar · 2020 · Frontiers in Neuroscience
  83. Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
    Basheer, Neha, Smolek, Tomáš, Hassan, Imtaiyaz, Liu, Fei, Iqbal, Khalid, Zilka, Norbert, Novak, Petr · 2023 · Molecular Psychiatry
  84. Interneuron Accumulation of Phosphorylated tau Impairs Adult Hippocampal Neurogenesis by Suppressing GABAergic Transmission.
    Jie Zheng, Hong-Lian Li, Na Tian, Fei Liu, Lu Wang, Ya-Ling Yin, Lu-Peng Yue, Longyu Ma, Y. Wan, Jian-Zhi Wang · 2020 · Cell Stem Cell
  85. AD-linked R47H- <i>TREM2</i> mutation induces disease-enhancing microglial states via AKT hyperactivation
    Sayed, Faten A., Kodama, Lay, Fan, Li, Carling, Gillian K., Udeochu, Joe C., Le, David, Li, Qingyun, Zhou, Lu, Wong, Man Ying, Horowitz, Rose et al. · 2021 · Science Translational Medicine
  86. TREM2 Function in Alzheimer’s Disease and Neurodegeneration
    Ulrich, Jason D., Holtzman, David M. · 2016 · ACS Chemical Neuroscience
  87. Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease
    Zhang, Zhentao, Obianyo, Obiamaka, Dall, Elfriede, Du, Yuhong, Fu, Haian, Liu, Xia, Kang, Seong Su, Song, Mingke, Yu, Shan-Ping, Cabrele, Chiara et al. · 2017 · Nature Communications
  88. Progranulin expression in the developing and adult murine brain
    Petkau, Terri L., Neal, S.J., Orban, P.C., MacDonald, J.L., Hill, A.M., Lu, G., Feldman, H.H., Mackenzie, I.R.A., Leavitt, B.R. · 2010 · Journal of Comparative Neurology
  89. The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade
    Chao Wang, Alexey G. Klechikov, Anna L. Gharibyan, Sebastian K.T.S. Wärmländer, Jüri Jarvet, Lina Zhao, Xueen Jia, S.K. Shankar, Anders Olofsson, Thomas Brännström et al. · 2013 · Acta Neuropathologica
  90. TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
    Maxime W.C. Rousseaux, María de Haro, Cristian A. Lasagna‐Reeves, Antonia De Maio, Jeehye Park, Paymaan Jafar‐Nejad, Ismael Al‐Ramahi, Ajay Sharma, Lauren See, Nan Lü et al. · 2016 · eLife
  91. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment–dementia converters measured by positron emission tomography with [11C]DAA1106
    Yasuno, Fumihiko, Kosaka, Jun, Ota, Miho, Higuchi, Makoto, Ito, Hiroshi, Fujimura, Yota, Nozaki, Shoko, Takahashi, Sho, Mizukami, Katsuyoshi, Asada, Takashi et al. · 2012 · Psychiatry Research: Neuroimaging
  92. Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
    Maria Teresa Ferretti, Martin Alejandro Bruno, Adriana Ducatenzeiler, William L. Klein, A. Claudio Cuello · 2011 · Neurobiology of Aging
  93. Immunoglobulins and complement in postmortem multiple sclerosis tissue
    Michael Harry Barnett, John D. E. Parratt, Eun‐Sook Cho, John W. Prineas · 2009 · Annals of Neurology
  94. Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
    Norbert Žilka, Zuzana Kazmerova, Santosh Jadhav, Peter Neradil, Aladár Maďari, Dominika Obetkova, Ondrej Bugos, Michal Novák · 2012 · Journal of Neuroinflammation
  95. Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease
    Tara E. Tracy, Li Gan · 2018 · Current Opinion in Neurobiology
  96. Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
    Sethu Sankaranarayanan, Donna M. Barten, Laurel Vana, Nino Devidze, Ling Yang, Gregory W. Cadelina, Nina Hoque, Lynn B. DeCarr, Stefanie Keenan, Alan Lin et al. · 2015 · PLoS ONE
  97. Widespread tau seeding activity at early Braak stages
    Jennifer L. Furman, Jaime Vaquer‐Alicea, Charles L. White, Nigel J. Cairns, Peter T. Nelson, Marc I. Diamond · 2016 · Acta Neuropathologica
  98. Cell-to-Cell Transmission of Tau and α-Synuclein
    Norihito Uemura, Maiko T. Uemura, Kelvin C. Luk, Virginia M.‐Y. Lee, John Q. Trojanowski · 2020 · Trends in Molecular Medicine
  99. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
    Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Ris, Laurence, Wang, Peng, Villers, Agnès, Peeraer, Eve, Buist, Arjan, Terwel, Dick, Baatsen, Peter, Oyelami, Tutu et al. · 2015 · Acta Neuropathologica
  100. Sevoflurane Induces Tau Phosphorylation and Glycogen Synthase Kinase 3β Activation in Young Mice
    Guorong Tao, Jie Zhang, Lei Zhang, Yuanlin Dong, Buwei Yu, Gregory J. Crosby, Deborah J. Culley, Yiying Zhang, Zhongcong Xie · 2014 · Anesthesiology